The BIO International Convention attracted approximately 10,000 biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships. They brought together a wide spectrum of life science and application innovators, including drug discovery, biomanufacturing, genomics, nanotechnology, and cell therapy.
As a proud sponsor of this international conference, we had two panel presentations discussing how we can help pharma and new and emerging biotech companies turn pharmaceutical possibilities into realities and get to market faster.
Nirupama Pike’s panel discussion, “Current realities of make vs. buy for cell & gene therapy manufacturing”, included speakers:
An additional panel conferred “Getting It Right: How Early Engagements with CDMOs Add Value to Small Biotechs” with:
If we did not see you at BIO, please request a meeting so we can discuss how we can assist in your processes.
Your request has been submitted. One of our business development executives will reach out shortly to set up your meeting.